Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if the addition of valproic acid to standard
platinum-based chemoradiation as definitive treatment of locally advanced Head and Neck
squamous cell carcinoma can improve treatment outcomes, such as response rate.